tiprankstipranks
Dermata Therapeutics (DRMA)
NASDAQ:DRMA
US Market
DRMA
Dermata Therapeutics
RESEARCH TOOLSreports

Dermata Therapeutics (DRMA) Income Statement

153 Followers

Dermata Therapeutics Income Statement

Last quarter (Q4 2025), Dermata Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Dermata Therapeutics's net income was $-1.86M. See Dermata Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 7.77M$ 12.51M$ 8.04M$ 9.67M$ 7.86M
Depreciation and Amortization
$ 0.00$ 0.00$ 8.04M$ 0.00$ 0.00
EBITDA
$ -7.77M$ -12.29M$ 247.22K$ -9.61M$ -7.86M
Operating Income
$ -7.77M$ -12.51M$ -8.04M$ -9.67M$ -7.86M
Other Income/Expenses
$ 215.04K$ 225.78K$ 247.22K$ 63.57K$ -45.61K
Pretax Income
$ -7.56M$ -12.29M$ -7.79M$ -9.61M$ -7.90M
Net Income
$ -7.56M$ -12.29M$ -7.79M$ -9.61M$ -7.90M
Per Share Metrics
Basic EPS
$ -8.16$ -80.32$ -401.80$ -139.20$ -152.70
Diluted EPS
$ -8.16$ -80.32$ -399.81$ -139.20$ -152.70
Weighted Average Shares Outstanding
 926.19K 153.00K 19.40K 69.07K 52.05K
Weighted Average Shares Outstanding (Diluted)
 926.19K 153.00K 19.50K 69.07K 52.05K
Currency in USD

Dermata Therapeutics Earnings and Revenue History